Matches in SemOpenAlex for { <https://semopenalex.org/work/W3023450964> ?p ?o ?g. }
- W3023450964 abstract "Background: Epilepsy is a serious health problem worldwide. Despite the introduction of new antiepileptic drugs (AEDs) almost 30% of these patients have drug-resistant forms of the disease (DRE), with a significant increase in morbi-mortality. Objective: Our objective was to assess the impact of some genetic factors and its possible association with treatment response and adverse drug reactions (ADRs) to phenytoin in 67 adult Colombian patients with epilepsy. Methods: We conducted an analytical, observational, prospective cohort study to screen four polymorphisms in pharmacogenes: CYP2C9*2 c.430C>T (rs1799853), CYP2C9*3 c.1075A>C (rs1057910), ABCB1 c.3435T>C (rs1045642) and SCN1A IVS5-91 G>A (rs3812718), and their association with treatment response. Patients were followed for one year to confirm the existence of DRE (non-response) and ADRs using an active pharmacovigilance approach, followed by a consensus in order to classify ADRs according to causality, preventability, intensity and their relation with phenytoin dose, the duration of treatment, and susceptibility factors (DoTS methodology). Results: A little more than half of evaluated subjects (52,2%) were non-responding to phenytoin. Regarding the genotype-phenotype correlation there was no association between polymorphisms of SCN1A and ABCB1 and DRE (non-response) (p = 0,34), and neither with CYP2C9 polymorphisms and the occurrence of ADRs (p = 0,42). We only found an association between polymorphic alleles of CYP2C9 and vestibular-cerebellar ADRs (dizziness, ataxia, diplopia and dysarthria) (p = 0.001). Alleles CYP2C9- c.430C>T and CYP2C9- c.1075A>C were identified as susceptibility factors to ADRs in 24% of patients. Conclusions: Polymorphic alleles of CYP2C9 were highly predictive of vestibular-cerebellar ADRs to phenytoin in our study (p = 0,001). However, the genetic variants CYP2C9-c.430C>T, CYP2C9- c.1075A>C, ABCB1-c.3435T>C and SCN1A-IVS5-91G>A, were not associated with treatment response in our study." @default.
- W3023450964 created "2020-05-13" @default.
- W3023450964 creator A5015359960 @default.
- W3023450964 creator A5020504914 @default.
- W3023450964 creator A5027323041 @default.
- W3023450964 creator A5037032884 @default.
- W3023450964 creator A5038909538 @default.
- W3023450964 creator A5050385468 @default.
- W3023450964 creator A5065707496 @default.
- W3023450964 creator A5067780812 @default.
- W3023450964 creator A5076878765 @default.
- W3023450964 creator A5078105473 @default.
- W3023450964 date "2020-05-07" @default.
- W3023450964 modified "2023-10-01" @default.
- W3023450964 title "Possible Genetic Determinants of Response to Phenytoin in a Group of Colombian Patients With Epilepsy" @default.
- W3023450964 cites W1585529854 @default.
- W3023450964 cites W1604539019 @default.
- W3023450964 cites W186640681 @default.
- W3023450964 cites W1892716386 @default.
- W3023450964 cites W1920696238 @default.
- W3023450964 cites W1950472309 @default.
- W3023450964 cites W1974809694 @default.
- W3023450964 cites W1988464252 @default.
- W3023450964 cites W1998278494 @default.
- W3023450964 cites W2023678134 @default.
- W3023450964 cites W2029855681 @default.
- W3023450964 cites W2034204487 @default.
- W3023450964 cites W2045655397 @default.
- W3023450964 cites W2054458932 @default.
- W3023450964 cites W2064701493 @default.
- W3023450964 cites W2067978628 @default.
- W3023450964 cites W2078225817 @default.
- W3023450964 cites W2093313595 @default.
- W3023450964 cites W2095131054 @default.
- W3023450964 cites W2098738258 @default.
- W3023450964 cites W2110135993 @default.
- W3023450964 cites W2141356899 @default.
- W3023450964 cites W2144365512 @default.
- W3023450964 cites W2163247758 @default.
- W3023450964 cites W2171279314 @default.
- W3023450964 cites W2403839061 @default.
- W3023450964 cites W2409829112 @default.
- W3023450964 cites W2569621292 @default.
- W3023450964 cites W2579298745 @default.
- W3023450964 cites W2580573398 @default.
- W3023450964 cites W2588710572 @default.
- W3023450964 cites W2795255825 @default.
- W3023450964 cites W2896370986 @default.
- W3023450964 cites W3157419554 @default.
- W3023450964 cites W4232195096 @default.
- W3023450964 cites W4376848378 @default.
- W3023450964 doi "https://doi.org/10.3389/fphar.2020.00555" @default.
- W3023450964 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7221122" @default.
- W3023450964 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32457604" @default.
- W3023450964 hasPublicationYear "2020" @default.
- W3023450964 type Work @default.
- W3023450964 sameAs 3023450964 @default.
- W3023450964 citedByCount "8" @default.
- W3023450964 countsByYear W30234509642020 @default.
- W3023450964 countsByYear W30234509642021 @default.
- W3023450964 countsByYear W30234509642022 @default.
- W3023450964 countsByYear W30234509642023 @default.
- W3023450964 crossrefType "journal-article" @default.
- W3023450964 hasAuthorship W3023450964A5015359960 @default.
- W3023450964 hasAuthorship W3023450964A5020504914 @default.
- W3023450964 hasAuthorship W3023450964A5027323041 @default.
- W3023450964 hasAuthorship W3023450964A5037032884 @default.
- W3023450964 hasAuthorship W3023450964A5038909538 @default.
- W3023450964 hasAuthorship W3023450964A5050385468 @default.
- W3023450964 hasAuthorship W3023450964A5065707496 @default.
- W3023450964 hasAuthorship W3023450964A5067780812 @default.
- W3023450964 hasAuthorship W3023450964A5076878765 @default.
- W3023450964 hasAuthorship W3023450964A5078105473 @default.
- W3023450964 hasBestOaLocation W30234509641 @default.
- W3023450964 hasConcept C104317684 @default.
- W3023450964 hasConcept C118552586 @default.
- W3023450964 hasConcept C126322002 @default.
- W3023450964 hasConcept C135763542 @default.
- W3023450964 hasConcept C187212893 @default.
- W3023450964 hasConcept C197934379 @default.
- W3023450964 hasConcept C23131810 @default.
- W3023450964 hasConcept C2778186239 @default.
- W3023450964 hasConcept C2778337148 @default.
- W3023450964 hasConcept C2779253243 @default.
- W3023450964 hasConcept C2780906641 @default.
- W3023450964 hasConcept C3946865 @default.
- W3023450964 hasConcept C526171541 @default.
- W3023450964 hasConcept C54355233 @default.
- W3023450964 hasConcept C55775858 @default.
- W3023450964 hasConcept C57658597 @default.
- W3023450964 hasConcept C62231903 @default.
- W3023450964 hasConcept C71924100 @default.
- W3023450964 hasConcept C72563966 @default.
- W3023450964 hasConcept C86803240 @default.
- W3023450964 hasConcept C98274493 @default.
- W3023450964 hasConceptScore W3023450964C104317684 @default.
- W3023450964 hasConceptScore W3023450964C118552586 @default.
- W3023450964 hasConceptScore W3023450964C126322002 @default.
- W3023450964 hasConceptScore W3023450964C135763542 @default.
- W3023450964 hasConceptScore W3023450964C187212893 @default.